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Partial left ventriculectomy (PLV) was initially performed
by Brazilian surgeon Randas Batista (1) with the rationale
that resection of a viable “slice” of the lateral left ventricular
(LV) wall in patients with dilated cardiomyopathy (DCM)
would reduce LV diameter and therefore wall stress (2).
Although early results with this procedure in uncontrolled
trials were promising and generated significant enthusiasm
(2), outcomes of subsequent clinical results have been
mixed (3).
This issue of the Journal includes two articles that
describe clinical outcomes after Batista’s operation. The
article by Schreuder et al. (4) describes the effect of PLV on
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LV pressure, volume and wall stress in eight patients
immediately before and after PLV, whereas the article by
Starling et al. (5) describes the effect of PLV on right heart
pressures and flow, LV pressure and volume, and exercise
capacity in 18 event-free survivors (freedom from death, left
ventricular assist device, or return of New York Heart
Association [NYHA] functional class IV failure) one year
after PLV (59 original operations). These studies present us
with an opportunity to reassess the physiologic rationale for
PLV and to determine future research and therapeutic
directions.
Both studies are nonrandomized clinical trials in patients
with NYHA class III–IV heart failure. Of note, in most
cases PLV was accompanied by mitral valve repair (88% to
93%) (4,5). Schreuder et al. (4) describe significant reduc-
tions in volume index at end-diastole (LVEDVI) and peak
wall stress after PLV. Starling et al. (5) conclude that,
although LVEDVI was significantly decreased and NYHA
class and peak VO2 rose significantly in event-free survivors,
there were minimal changes in stroke volume, cardiac index,
mean pulmonary, and pulmonary capillary wedge pressures.
The basis for the increase in VO2 is therefore unclear and
may be from improved medical management or placebo
effect (5).
Volume and stress reduction. The ability of the conduc-
tance catheter to measure absolute LV volume as used by
Schreuder et al. (4) is of concern. Measurement of LV
volume with the conductance catheter has been described by
Baan et al. (6) and includes calibration of the catheter
against a known flow standard and measurement of parallel
conductance (Vp). However, even with careful calibration
and frequent Vp measurement, the conductance catheter
may not be a good measure of absolute LV volume. The Vp
may vary with LV end-diastolic volume (7). In addition, the
amount of saline in the pericardial space (8), metal sternal
retractors (9) and temperature (10) all have been shown to
affect Vp. As an example, Figure 1 is a measure of agreement
(11) between stroke volume measured by thermodilution
and stroke volume measured with the conductance catheter
constructed from the data (Table 2) of Schreuder et al. (4).
This analysis shows a mean difference of approximately 20
ml and multiple differences greater than 40 ml. The relative
contribution of Vp and calibration to this error is unknown.
However, it would seem reasonable to corroborate conduc-
tance catheter measures of absolute LV volume with echo-
cardiography or nuclear radiography whenever possible and
use the conductance catheter for relative volume changes
only (12,13). Nonetheless, the decrease in LV volume
reported by Schreuder et al. (4) is large, and earlier reports
have consistently documented a decrease in end-diastolic
and end-systolic LV volumes with PLV (14,15).
It also seems reasonable that PLV reduces LV wall stress.
However, the stress calculation described by Arts et al. (16)
and used by Schreuder et al. (4) is based on a thick-walled
sphere and assumes that muscle fiber stress and strain are
homogeneously distributed in the normal LV. Furthermore,
the LV undergoes a significant shape change after partial
ventriculectomy and stress may not be uniformly distributed
in the dilated LV before or after partial ventriculectomy.
Certainly, in the region of the surgical incision there may be
local stress concentration and tethering of the area around
the suture line. Also, this analysis ignores any contribution
from increased residual stress after partial ventriculectomy.
Therefore, the wall-stress calculations are a gross simplifi-
cation and probably add nothing beyond the individual
pressure and volume data. Only finite element simulations
(see subsequent text) are able to take into consideration
nonuniform geometry, local differences in myocardial stiff-
ness and residual stress (17).
Failure to improve LV function. The reduction in LV
volume and wall stress accomplished by PLV may not be
sufficient to improve LV function. For instance, early
reports documented a heterogeneous effect of partial ven-
triculectomy on ventricular function (18,19). Although
most reports document a decrease in stroke volume (14,15),
stroke volume and cardiac index (19) also have been noted
to improve. However, because postoperative ventricular
end-diastolic pressure often varies widely (14,19) and heart
rate is increased (14), these data are difficult to interpret. In
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addition, concomitant mitral valve repair makes static data
almost impossible to interpret.
We suggest that the success of an operation that surgi-
cally remodels LV size, shape or regional stiffness depends
on how the procedure affects both end-systolic pressure-
volume (elastance) and diastolic pressure-volume (compli-
ance) relationships, and how those changes affect ventricular
function (e.g., stroke volume vs. end-diastolic pressure
[Starling] relationship) (20). The effect of partial ventricu-
lectomy on load independent end-systolic and diastolic
pressure-volume relationships has been measured with ven-
triculography (21), conductance catheter (15) and two-
dimensional echocardiography (18). End-systolic elastance
has been found to increase by two- to threefold (15,21) and
diastolic compliance significantly decreases (15,18). How-
ever, the Starling relationship has not been measured.
Mathematical (finite element) models. Finite element
analysis (FEA) relates regional material properties, struc-
tural shape and regional stress as a system of linear equations
(22). Given accurate initial conditions, FEA is able to
include nonuniform geometry, local differences in myocar-
dial stiffness and residual stress and then calculate the effect
of LV volume-reduction surgery on end-systolic elastance,
diastolic compliance and ventricular function (17). Given
the lack of a large animal model of dilated cardiomyopathy
suitable for experimental testing, finite element modeling
may provide the best analysis of PLV. It may also provide a
test bed with which to evaluate new operations for dilated
cardiomyopathy.
We have previously described a simple finite element
model of partial left ventriculectomy (17). That simulation
shows that PLV causes diastolic compliance to shift farther
to the left on the pressure-volume diagram than end-systolic
elastance. As a consequence, PLV decreases the slope of the
Starling relationship, suggesting that PLV decreases cardiac
pump function. These predicted relative shifts in the LV
compliance and elastance have been corroborated by the
experimental studies of Kawaguchi et al. (15) and the
mathematical multicompartment model of Dickstein et al.
(23), which also confirmed depression of the Starling
relationship.
Of note, an improvement in ejection fraction (EF) or
preload recruitable stroke work (PRSW) does not mean that
PLV is successful. Although EF has consistently increased
(14,19), mathematical models predict a decrement in the
Starling relationship even when EF and PRSW are im-
proved (17,23). Independent variables, such as EF or
PRSW, that are mathematically dependent on changes in
LV volume and must change when LV volume is reduced
are poor predictors of LV function in the setting of
ventricular remodeling surgery.
Statistical issues. Repeated measures analysis of variance
(ANOVA) typically excludes cases with missing data. Al-
though techniques exist to estimate small amounts of
missing data (24), the amount of missing data (Table 2; 3 of
8 complete data sets) in Schreuder et al. would seem to
preclude a meaningful repeated measures analysis (4).
Also of concern are the statistical methods employed by
Starling et al (5). Specifically, patients who do well (event-
free) are selected over time, and while it appears in this
series that volume, EF and exercise tolerance were stable,
this may not be the case for the entire group. We would like
to learn from Batista’s operation, and although it is inter-
esting to know the characteristics of event-free survivors, of
more interest might be the characteristics of those in whom
the operation failed. Survival analysis may be a more
appropriate way to test factors that are related to early
postoperative deterioration in pump function and late post-
operative redilation (see subsequent text) (25).
Clinical outcomes. Short- and mid-term follow-up from
the Cleveland Clinic has been previously reported (3).
Operative mortality was 3.2% and 16% (10/62) of patients
who required LVAD placement for cardiogenic shock.
Survival was 78% and 68%, but event-free survival was only
50% and 37% at one and two years, respectively (3).
Because a control group was not employed, it is in-
structive to consider the outcomes of patients with NYHA
class III–IV heart failure treated with other therapies. For
instance, beta-blocker therapy has significantly reduced the
mortality of NYHA class III–IV heart failure. Recent
studies including CIBIS-II (mortality [mean follow-up
1.3 years]: placebo 17.3%, Bisoprolol 11.8%) (26) and
COPERNICUS (annual mortality: placebo 18.5%, Carve-
dilol 11.4%) (27) were both stopped early because of
significant mortality benefit. In addition, mitral valve repair
alone has one- and two-year survivals of 82% and 71% in
NYHA class III–IV heart failure (28). Because survival rates
are so similar, it would seem reasonable to randomize future
studies (i.e., beta-blockers vs. PLV 1 beta-blockers) so that
the most effective therapies can be determined.
Postoperative redilation. Patients who have undergone
both left ventricular (LV) patch aneurysmorrhaphy (29) and
PLV (19) have experienced LV dilation at one year. Dor et
al. found that end-systolic and end-diastolic ventricular
volume increased 22% and 29%, respectively, after patch
repair (29), and Moreira et al. reported that end-systolic and
end-diastolic ventricular volume increased after PLV (19).
Figure 1. Measure of agreement between stroke volume measured by
thermodilution and stroke volume measured with the conductance catheter
constructed from the data of Schreuder et al. (4) (Table 2). Note the mean
difference of 18.4 ml.
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The cause of this postoperative remodeling is unclear but
may include progression of the underlying biologic disease
process, infarction and stretching at the suture line, lack of
pericardial support and increased wall stress secondary to
the aneurysm repair. Of note, a recent report documented
scar (suture line) expansion after PLV (30).
Conclusions. Batista’s operation was an intriguing and
potentially important surgical therapy for patients with
dilated cardiomyopathy and congestive heart failure. Partial
left ventriculectomy is able to reduce LV volume and
probably decreases ventricular wall stress. However, reduc-
tion of volume and stress is not sufficient to improve
ventricular function. Specifically, finite element simulations
of partial left ventriculectomy show that diastolic compli-
ance shifts further to the left on the pressure-volume
diagram than end-systolic elastance. The net result is a
decrement in the Starling relationship. Peri-operative data
are difficult to interpret, but in general they are consistent
with these predictions.
In addition, clinical results have been disappointing.
Event-free survival is poor (37% at two years) (3). Further-
more, because clinical trials were not randomized, it is not
clear that surgical results are different from those obtained
with current state-of-the-art medical and surgical therapy.
The apparent failure of partial left ventriculectomy does
not imply that all surgical operations that intend to reduce
the dilated LV are impractical. For instance, the Myocor
interventricular splint and surgical procedures that restore
ventricular shape after post-infarction remodeling such as
the Dor procedure (29) and radiofrequency infarct heating
(31) may reduce stress without a reduction in ventricular
function.
As discussed, finite element simulations may serve as a
useful test bed with which to evaluate new operations for
dilated cardiomyopathy. In addition, improvements in tech-
nology may allow the noninvasive measurement of material
properties in the future. For instance, Moulton et al. (32,33)
have back-calculated myocardial material properties from
magnetic resonance measurements of myocardial strain. We
hope that, in the future, knowledge of regional material
properties may serve as input into mathematical simulations
allowing surgeons to individualize design of reparative
operations for patients with dilated cardiomyopathy and
congestive heart failure.
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